
Arx Equity Partners sells Lexum to Moonray Healthcare
Arx Equity Partners has sold Czech ophthalmology and refractive surgery provider Lexum to British healthcare investor Moonray Healthcare.
Following the transaction, Moonray Healthcare will combine Lexum with Optegra, which operates hospitals specialised in eye surgery across the UK and Germany.
Arx acquired Lexum in April 2009 for less than €25m. Equity for the deal was sourced from Arx CEE III; Landesbank Baden-Wuerttemberg provided debt for the transaction.
In February 2010, Arx backed Lexum's acquisition of Polish ophthalmology chain Intermedica.
Company
Lexum operates 10 hospitals offering ophthalmology and refractive surgery treatment in the Czech Republic and Poland. Sites are located in Prague, Ceske Budejovice, Ostrava, Brno, Tabor, Poznan, Krakow, Szczecin, Warsaw and Wroclaw. Lexum employs 40 surgical ophthalmologists.
People
Tim Clover is CEO of Moonray Healthcare and Optegra. Martin Filipex, the founder and current CEO of Lexum, will continue to work with the company as chief medical officer.
Advisers
Equity – KPMG (Financial due diligence); DLA Piper (Legal).
Vendor – White & Case (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater